Umberto Pensato: New BMJ Review on Breakthrough Stroke in Patients Receiving DOACs Is Now Live
Umberto Pensato, Assistant Professor of Neurology at the Humanitas University, Research Collaborator at the University of Calgary, shared on LinkedIn about a recent article he and his colleagues co-authored, published in BMJ, adding:
”Out now on the BMJ, our comprehensive review on breakthrough stroke (stroke despite DOAC) which accounts for nearly one in seven ischemic stroke in daily practice (yet has been largely neglected until recently).
Here we review the epidemiology, mechanisms, a framework for classification, and mangement of this condition.
Notably, we also propose a systematic, stepwise algorithm for investigation, along with standardized criteria to select patients for future randomized clinical trials (AF-BREACH criteria)
Kudos to Ronda Lun for leading this review over the last two years and pulling together a terrific international, multidisciplinary team covering neurology, cardiology, and hematology.”
Title: Investigation and management of breakthrough ischemic stroke in anticoagulated patients with atrial fibrillation
Authors: Ronda Lun, Umberto Pensato, Joseph R. Shaw, Carlo A. Pivato, Luciano A. Sposato, Thalia S. Field, Andrew M. Demchuk

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 16:09Elad Anter։ A New Map of Atrial Fibrillation Initiation
-
Sep 11, 2026, 15:55Marwa Mostafa: The Paradox of Sideroblastic Anemia
-
Sep 11, 2026, 15:37Empowering Local Stakeholders to Advance Hemophilia Care in Côte d’Ivoire – World Federation of Hemophilia
-
Sep 11, 2026, 15:34Dhargam Aljebouri: A New Milestone for Transfusion Education in Iraq
-
Sep 11, 2026, 15:17Shadi Tabibian: Where Laboratory Precision Meets Clinical Care
-
Sep 11, 2026, 14:58Kevin Land: Connecting Donors to Patients Across the Spectrum of Care
-
Sep 11, 2026, 14:45Jorge Mascaro: The Growing Impact of the UK Aortic Society on Aortic Disease Care
-
Sep 11, 2026, 14:31Hany Ibrahim: Lp(a) Lowering Meets a Critical Test in the Lp(a)HORIZON Trial
-
Sep 11, 2026, 13:35How Non-Factor Therapies Are Changing Hemophilia Care – Seminars in Thrombosis and Hemostasis